2025/11/14 AD
Deficiency in Sterility Assurance by Sterilization Validation
PMDA ORANGE LETTER_2025.08
2025/10/23 AD Quality System
What the Revised GMP Ministerial Ordinance changed.
On Establishing the Required Structure for a Modern QA Department [Part 2]
2025/09/03 AD Quality System
On Establishing the Required Structure for a Modern QA Department [Part 1]
2025/08/06 AD Quality System
Fact from 2,500 of FDA Form 483s
Data Integrity Issue Trend on FDA Inspections
2025/08/05 AD
Problems Behind Discrepancies with product authorization requirements
PMDA ORANGE LETTER_2025.05
2025/07/15 AD
Deficiencies in multi-purpose manufacturing site
PMDA ORANGE LETTER_2025.03
2025/05/15 AD
PMDA ORANGE LETTER_2025.01
2025/01/23 AD
Findings related to discrepancies with approved dossier and fake record
PMDA ORANGE LETTER_2024.10
医薬品の技術移転のポイント【第3回】
Morio Wakisaka
Ryoichi Tanaka
You will be navigated to the CM Plus company website.
CM Plus Group Website
This website uses cookies to offer a better browsing experience. By clicking "Accept," you agree to use cookies for the purpose detailed in our privacy policy.